Scholar Rock updates apitegromab regulatory status in U.S., Europe, Japan
Go back to Scholar Rock updates apitegromab regulatory status in U.S., Europe, Japan| (NASDAQ: SRRK) | Delayed: 50.70 +2.54 (5.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.16 | 52 Week High | $ | |||
| Open | $48.07 | 52 Week Low | $ | |||
| Day High | $51.45 | P/E | N/A | |||
| Day Low | $48.07 | EPS | $ | |||
| Volume | 961,046 | |||||

